Background Coronavirus disease 2019 (COVID-19) is a rapidly emerging disease that has
been classified a pandemic by the World Health Organization (WHO). In the absence of …

Background Ethiopia has adopted the global plan to end the epidemic of HIV/AIDS. The aim
of this study was to assess the progress made towards achieving this plan. Methods A …

Introduction Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that
is awareness of HIV‐positive status, receipt of antiretroviral (ARV) therapy among aware …

Background. Studies have shown high early mortality after initiation of highly active
antiretroviral therapy (HAART). We examined change in three-year survival and predictors of …

Background The HIV epidemic in Ethiopia is concentrated in urban areas. Ethiopia conducted
a Population-based HIV Impact Assessment (EPHIA) in urban areas between October …

Background: Women are disproportionally affected by HIV and are at greater risk of OIs and
malignancies. This study investigated the spectrum of OIs and malignancies among women …

Background Despite recent advances in human immunodeficiency virus-1 (HIV-1)
prevention, a fast, safe, and effective vaccine will probably be necessary to end the HIV/AIDS …

Background: High rates of disease progression and HIV drug resistance (HIVDR) among
adults taking highly active antiretroviral treatment (HAART) in Sub-Saharan Africa were …

The design and evaluation of national HIV programs often rely on aggregated national data,
which may obscure localized HIV epidemics. In Ethiopia, even though the national adult HIV …

Objectives The aim of this study was to evaluate HIV-1 drug resistance among patients failing
first-line antiretroviral therapy in Ethiopia. Methods A total of 699 adults infected with HIV (…